Henne-Bruns D - Search Results

1

Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.

Juhl H, Helmig F, Baltzer K, Kalthoff H, Henne-Bruns D, Kremer B. Juhl H, et al. J Surg Oncol. 1997 Mar;64(3):222-30. doi: 10.1002/(sici)1096-9098(199703)64:3<222::aid-jso9>3.0.co;2-c. J Surg Oncol. 1997. PMID: 9121154

2

[Immunocytologic detection of micro-metastatic cells in patients with gastrointestinal tumors].

Juhl H, Kalthoff H, Krüger U, Henne-Bruns D, Kremer B. Juhl H, et al. Zentralbl Chir. 1995;120(2):116-22. Zentralbl Chir. 1995. PMID: 7709662 German.

3

[Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].

Juhl H, Kalthoff H, Krüger U, Schott A, Schreiber HW, Henne-Bruns D, Kremer B. Juhl H, et al. Chirurg. 1994 Dec;65(12):1111-5. Chirurg. 1994. PMID: 7851144 German.

4

Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.

Marxsen J, Schmiegel W, Röder C, Harder R, Juhl H, Henne-Bruns D, Kremer B, Kalthoff H. Marxsen J, et al. Br J Cancer. 1994 Nov;70(5):1031-4. doi: 10.1038/bjc.1994.443. Br J Cancer. 1994. PMID: 7947080 Free PMC article.

5

Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients.

Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, Neumaier M, Wagener C, Schreiber HW, Kalthoff H. Juhl H, et al. Int J Cancer. 1994 May 1;57(3):330-5. doi: 10.1002/ijc.2910570307. Int J Cancer. 1994. PMID: 8168992

6

Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR.

Soeth E, Vogel I, Röder C, Juhl H, Marxsen J, Krüger U, Henne-Bruns D, Kremer B, Kalthoff H. Soeth E, et al. Cancer Res. 1997 Aug 1;57(15):3106-10. Cancer Res. 1997. PMID: 9242433

7

Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer.

Schmiegel W, Schmielau J, Henne-Bruns D, Juhl H, Roeder C, Buggisch P, Onur A, Kremer B, Kalthoff H, Jensen EV. Schmiegel W, et al. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12622-6. doi: 10.1073/pnas.94.23.12622. Proc Natl Acad Sci U S A. 1997. PMID: 9356499 Free PMC article.

8

Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker.

Schott A, Vogel I, Krueger U, Kalthoff H, Schreiber HW, Schmiegel W, Henne-Bruns D, Kremer B, Juhl H. Schott A, et al. Ann Surg. 1998 Mar;227(3):372-9. doi: 10.1097/00000658-199803000-00009. Ann Surg. 1998. PMID: 9527060 Free PMC article.

9

Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.

Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kalthoff H. Ungefroren H, et al. Cancer Res. 1998 Apr 15;58(8):1741-9. Cancer Res. 1998. PMID: 9563493

10

Growth inhibition of pancreatic tumor cells by modified antisense oligodeoxynucleotides.

Fiedler A, Knorre C, Franke Y, Henne-Bruns D, Kremer B, Lüttges J, Maier M, Gerster M, Bleicher K, Bayer E, Kalthoff H. Fiedler A, et al. Langenbecks Arch Surg. 1998 Aug;383(3-4):269-75. doi: 10.1007/s004230050131. Langenbecks Arch Surg. 1998. PMID: 9776455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters